Variables Associated With Response to Therapy in Patients With Interstitial Pneumonia With Autoimmune Features.

Area of Science:

• Pulmonology
• Rheumatology
• Immunology

Background:

• Limited understanding of patient characteristics predicting treatment response in interstitial pneumonia with autoimmune features (IPAF).
• Published IPAF criteria were used to identify features associated with treatment response.

Purpose of the Study:

• To characterize serological, clinical, and morphological features associated with immunosuppressive treatment response in IPAF patients.
• To evaluate the effectiveness of different immunosuppressive regimens in managing IPAF.

Main Methods:

• Single-center medical records review of 63 IPAF patients.
• Response defined as <10% vital capacity decline and no death/transplant within one year of therapy.
• Statistical analysis included nonparametric measures and multivariate logistic regression.

Main Results:

• No statistically significant association found between baseline serological, clinical, or morphological features and immunosuppressive response.
• Combination therapy with mycophenolate mofetil and prednisone was linked to less disease progression (p=0.018).

Conclusions:

• Baseline clinical assessment did not predict immunosuppressive therapy response in IPAF.
• Combination therapy with mycophenolate mofetil and prednisone demonstrated a lack of disease progression in IPAF patients.
• Further research is needed to determine optimal treatment strategies, including immunosuppression and antifibrotic therapy.